| Ident. | Authors (with country if any) | Title |
|---|
| 000049 (2012) |
Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France] | Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence |
| 000051 (2008) |
Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi | Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary |
| 000088 (2011) |
Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis] | Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach |
| 000134 (2013) |
F. Behrens [Allemagne] ; M. Köhm [Allemagne] | Personalisierte Medizin bei Zytokin-gerichteten Therapien |
| 000189 (2013) |
Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal] | Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events |
| 000366 (2013) |
J. E. Pope ; E. Rampakakis ; J. Sampalis ; O. Desjardins [Canada] | FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF |
| 000438 (2013) |
E. Tanaka [Japon] ; E. Inoue [Japon] ; D. Hoshi [Japon] ; A. Kobayashi [Japon] ; N. Sugimoto [Japon] ; K. Shidara [Japon] ; E. Sato [Japon] ; Y. Seto [Japon] ; A. Nakajima [Japon] ; S. Momohara [Japon] ; A. Taniguchi [Japon] ; H. Yamanaka [Japon] | AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database |
| 000441 (2013) |
V. Rodríguez-García [Espagne] ; M. Ord Ez [Espagne] ; S. Manrique-Arija [Espagne] ; C. Romero-Barco [Espagne] ; L. Nieves-Martín [Espagne] ; I. Ure A [Espagne] ; F. Jiménez-Nú Ez [Espagne] ; B. Panero [Espagne] ; M. Belmonte-Lopez [Espagne] ; L. Cano-García [Espagne] ; V. Coret [Espagne] ; M. Irigoyen [Espagne] ; A. Fernández-Nebro [Espagne] | AB0583 Effectiveness and safety of short-term treatment of active rheumatoid arthritis (RA) moderate to severe with tocilizumab |
| 000446 (2013) |
Vasco C. Romão [Portugal] ; Maria José Santos [Portugal] ; José Canas Da Silva [Portugal] ; Joaquim Polido Pereira [Portugal] ; José Alberto Pereira Da Silva [Portugal] ; Cátia Duarte [Portugal] ; José Ant Nio Pereira Da Silva [Portugal] ; Cândida Silva [Portugal] ; Ana Assunção Teixeira [Portugal] ; José Antonio Costa [Portugal] ; Domingos Araújo [Portugal] ; Fernando Pimentel Santos [Portugal] ; Jaime Branco [Portugal] ; José Ant Nio Melo Gomes [Portugal] ; Augusto Faustino [Portugal] ; João Eurico Fonseca [Portugal] ; Helena Canhão [Portugal] | A10.5 Comparative Effectiveness of Biological Therapies in Rheumatoid Arthritis is Influenced by Response Measures and Disease Activity State |
| 000461 (2011) |
Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie] | Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator |
| 000511 (2011) |
Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne] | Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study |
| 000529 (2013) |
J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni] | AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study |
| 000557 (2013) |
C. Zerbini [Brésil] ; J. Orozco [Mexique] ; M. Martinez [Chili] ; J. Jaller [Colombie] ; A. Quinteros [Argentine] ; Y. Finol ; J. Facal [Uruguay] ; R. Villacís [Équateur] ; J. Alfaro [Pérou] ; P. Faustino [Brésil] ; R. Sáenz [Costa Rica] | AB0521 A single-arm, open-label study of the safety and effectiveness of tocilizumab in combination with methotrexate, in patients with rheumatoid arthritis in latin america – preliminary effectiveness results-ritmo study |
| 000560 (2013) |
L. Harrold ; A. John ; G. Reed ; W. Reiss ; R. Magner ; C. Y. Chung ; K. C. Saunders ; J. M. Kremer ; J. D. Greenberg [États-Unis] | AB0551 The use and effectiveness of rituximab in patients with rheumatoid arthritis observational study: Corrona registry |
| 000573 (2013) |
D. A. Pappas [États-Unis] ; A. John ; J. D. Greenberg [États-Unis] ; J. Devenport ; J. M. Kremer ; S. Ogale ; G. W. Reed ; K. C. Saunders ; J. R. Curtis [États-Unis] | AB0524 Design characteristics of the corrona certain study: A US comparative effectiveness and biomarker study of rheumatoid arthritis biologic agents |
| 000581 (2013) |
T. Takeuchi [Japon] ; Y. Tanaka ; K. Amano ; J. Kikuchi [Japon] ; E. Tanaka [Japon] ; S. Hirata ; H. Nagasawa ; H. Yasuoka [Japon] ; H. Yamanaka [Japon] | SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study |
| 000603 (2013) |
A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie] | AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA) |
| 000621 (2013) |
M. Pietrosanti [Italie] ; R. Di Rosa [Italie] ; S. Salemi [Italie] ; M. Markovic [Italie] ; V. Carusi [Italie] ; M. I. Biondo [Italie] ; M. Catoni [Italie] ; B. Laganà [Italie] ; M. L. Sorgi [Italie] ; R. D Melio [Italie] | AB0329 Clinical effectiveness and infection rate in rheumatoid arthritis patients switched from anti-tnf agents to abatacept |
| 000632 (2013) |
S. Manrique-Arija ; A. Fernandez-Nebro [Espagne] ; V. Coret ; L. Nieves ; V. Rodriguez-García ; C. M. Romero-Barco ; I. Ure A ; F. Jimenez-Nu Ez ; L. Cano ; M. A. Belmonte ; M. V. Irigoyen | AB0331 Analysis of the effectiveness of different doses of rituximab in a cohort of patients with rheumatoid arthritis |
| 000657 (2013) |
Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. Ishiguro | AB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy |
| 000721 (2016) |
J. E. Machado-Alba [Colombie] ; A. F. Ruiz [Colombie] ; M. E. Machado-Duque [Colombie] | Effectiveness of treatment with biologic‐ and disease‐modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia |
